Rhodomyrtone decreases expression of inflammatory transcripts by TNF-α+IL-17A stimulated in skin organ cultures. by Julalak Chorachoo (5855852)

“…Rhodomyrtone treatment decreases production of <i>DEFB4</i>, <i>IL1B</i>, <i>IL17C</i>, <i>IL36G</i>, <i>LCN2</i>, <i>PI3</i>, <i>S100A7</i>, and <i>S100A8</i> transcripts as measured by qRT-PCR at 72 h. …”

The Intracellular level of FLASH decreases during apoptosis. by Song Chen (69646)

PG treatment decreases HCC cell survival. by Po-Li Wei (292225)

rRL-KD treatment decreased inflammation after MSU-induced acute gout arthritis. by Fábio Mambelli (10005409)

Inhibition of Hsp90 decreased cellular apoptosis. by Raúl Orozco-Díaz (7067624)

Release-decreasing vs. release-increasing astrocytes. by Maurizio De Pittà (194237)

“…The nature of the change depends on the nature of presynaptic receptors. (<b>A</b>) For α = 0, the effect of the astrocytic glutamate is a global decrease of synaptic release, which fades away slowly from its onset at rate Ω_G (<i>green area</i>). …”

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…(E) ATRA and clodronate liposome treatment, composite from 2 sections. Scale bar: 100 μm in A and B. (F) Bar and scatter plots of the number of axons per transverse section, sampled at approximately 200 μm distal to the cut site, showing mean ± SEM. …”

Hsp90 depletion decreases stress resistance. by Michelle D. Leach (108675)

Modafinil decreased EEG amplitude in the synchronized model. by Chang-Rui Chen (467755)

Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) an... by Alexandra M. Campbell (3284094)

Increase of mitochondrial dysfunction and glycolysis by decreased NEFH. by Myoung Sook Kim (91321)

In the null model the event rate does not decrease as a function of the inverse of time. by Thomas O. Richardson (251876)

During electrical stimulation the decrease in compound action potential (CAP), but not of ATP, is larger in <i>Plp</i>^null/y mice. by Andrea Trevisiol (9647910)

S100A6-immunoreactivity in mouse brain structures. by Katarzyna Bartkowska (453261)

Subjects:

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Significant decrease of the viability of A375 melanoma cells after CD treatment. by Lena Berning (7430117)

Decrease of goblet cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

Decrease of Paneth cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. by Hyung-Ran Kim (532404)

Nivalenol (NIV) decreases chondrocyte viability in a dose and duration-dependent manner. by Siyuan Li (178640)